Intellectual Property Royalties
Invest in companies that own the rights to valuable ideas, not just physical products. This collection features businesses earning high-margin income from patents, music catalogs, and character franchises — carefully selected by our analysts to give you exposure to the economics of innovation itself.
Your Basket's Financial Footprint
Summary of total market capitalisation and constituent breakdown for the Intellectual Property Royalties basket.
- Large-cap dominance generally implies lower volatility and closer tracking of broad market performance, reducing idiosyncratic risk.
- Suitable as a core, long-term holding to anchor allocation rather than a speculative, short-term growth position.
- Expect steady, long-term value accretion rather than rapid, explosive gains; returns are not guaranteed.
RPRX: $21.86B
DIS: $205.50B
QCOM: $181.96B
- Other
About This Group of Stocks
Our Expert Thinking
These companies profit from owning intellectual assets like drug patents, music catalogs, and character rights. They generate income by licensing these valuable intangibles to others—collecting royalties without the complexity of manufacturing or delivering services themselves.
What You Need to Know
This collection focuses purely on intellectual property royalty generators, excluding commodity-based assets. These stocks can provide portfolio diversification through high-margin revenue streams that may be more resilient than traditional business models during economic fluctuations.
Why These Stocks
We've carefully selected pure-play royalty companies and firms with significant IP licensing divisions. The expanding digital economy and biotech advancements create continuous opportunities for these businesses to monetize valuable patents and copyrights in innovative ways.
Why You'll Want to Watch These Stocks
Ideas Are The New Gold
In today's digital economy, owning the rights to ideas can be more profitable than owning physical assets. These companies collect recurring payments simply for owning valuable IP.
Profit Without Production
These companies earn high-margin income without dealing with manufacturing costs or supply chain headaches. They simply collect checks when others use their intellectual property.
Streaming's Hidden Winners
As digital content consumption grows, the owners of music catalogs, characters, and technology patents quietly collect more royalties. It's like owning a toll bridge on the digital highway.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Drug Pricing Power | Major Pharma Stocks 2025
Following plans by major drugmakers to raise prices on hundreds of medications, the pharmaceutical industry is showcasing its significant pricing power. This development highlights an investment opportunity centered on established pharmaceutical companies capable of translating market dominance into revenue growth.
Automation & Software Investment Theme Overview
Recent labor data reveals a split market, with low private-sector jobless claims contrasting with high unemployment driven by federal layoffs. This dynamic creates an investment opportunity in companies providing automation, software, and efficiency-boosting services as businesses prioritize productivity over expanding their payrolls.
Oyo's IPO Plans: Hospitality Sector Recovery Explained
Global hospitality firm Oyo's parent company has revived its IPO plans, signaling renewed confidence in the travel market. This high-profile listing could ignite investor interest across the entire hospitality and travel technology sector, creating opportunities for related service providers.